XML 23 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Jan. 02, 2016
Jan. 03, 2015
Dec. 28, 2013
Cash flows from operating activities:      
Net income $ 85,279 $ 68,311 $ 108,967
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 269,904 269,517 98,787
Deferred income taxes 7,807 (21,216) 24,593
Loss/(gain) on sale of assets 1,311 (2,437) (1,245)
Gain on insurance proceeds from insurance settlement (561) (1,550) (1,981)
Increase/(decrease) in long-term pension liability (4,811) 9,593 (9,010)
Stock-based compensation expense 8,995 20,807 9,433
Write-off deferred loan costs 10,633 4,330 0
Deferred loan cost amortization 10,155 9,949 3,451
Equity in net (income)/loss of unconsolidated subsidiary (73,416) (65,609) (7,660)
Distributions of earnings from unconsolidated subsidiaries 26,589 0 0
Unrealized gain on foreign currency hedge 0 0 (27,516)
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable 8,214 982 4,424
Income taxes refundable 12,377 (22,451) (15,316)
Inventories and prepaid expenses 34,536 (11,194) 2,059
Accounts payable and accrued expenses (11,449) (31,223) 8,521
Other 35,785 47,363 13,214
Net cash provided by operating activities 421,348 275,172 210,721
Cash flows from investing activities:      
Capital expenditures [1] (229,848) (228,918) (118,307)
Acquisitions, net of cash acquired (377) (2,094,400) (734,075)
Investment in unconsolidated subsidiary 0 0 (44,959)
Gross proceeds from sale of property, plant and equipment and other assets 3,840 9,262 2,358
Proceeds from insurance settlement 561 1,550 1,981
Payments related to routes and other intangibles (3,845) (11,288) (2,423)
Net cash used in investing activities (229,669) (2,323,794) (895,425)
Cash flows from financing activities:      
Proceeds from long-term debt 590,745 1,842,184 344,704
Payments on long-term debt (609,255) (333,762) (580)
Borrowings from revolving credit facility 78,244 170,143 293,235
Payments on revolving credit facility (166,755) (351,589) (5,000)
Net cash overdraft financing (1,261) 4,077 0
Deferred loan costs (17,310) (45,223) (13,320)
Issuance of common stock 171 416 840,558
Repurchase of treasury stock (5,912) 0 0
Minimum withholding taxes paid on stock awards (4,874) (10,026) (3,289)
Excess tax benefit/(expense) from stock-based compensation (389) 2,420 1,138
Addition/(deductions) of noncontrolling interest (87) 1,201 0
Distributions to noncontrolling interests (3,295) (4,272) 0
Net cash provided/(used) in financing activities (139,978) 1,275,569 1,457,446
Effect of exchange rate changes on cash flows (3,601) 10,980 (5,134)
Net increase/(decrease) in cash and cash equivalents 48,100 (762,073) 767,608
Cash and cash equivalents at beginning of year 108,784 870,857 103,249
Cash and cash equivalents at end of year 156,884 108,784 870,857
Supplemental disclosure of cash flow information:      
Accrued capital expenditures 5,325 1,340 1,163
Cash paid during the year for:      
Interest, net of capitalized interest 78,979 104,834 21,554
Income taxes, net of refunds (3,035) 28,315 31,405
Non-cash financing activities      
Debt issued for service contract assets $ 2,591 $ 0 $ 0
[1] Excludes the capital assets acquired in an immaterial acquisition in fiscal 2015, the VION Acquisition and Custom Blenders acquisition in fiscal 2014 of approximately $984.2 million, the Terra Transaction and the Rothsay Acquisition in fiscal 2013 of approximately $167.0 million